Advertisement Johnson & Johnson completes acquisition of Mentor - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Johnson & Johnson completes acquisition of Mentor

Johnson & Johnson has completed its previously announced acquisition of Mentor, a supplier of medical products for the global aesthetic market.

Mentor is expected to operate as a stand-alone business unit reporting through Ethicon, a Johnson & Johnson company and a provider of suture, mesh and other products for a wide range of surgical procedures.

Gary Pruden, company group chairman of Johnson & Johnson, said: “Mentor will become the cornerstone of a broader Johnson & Johnson strategy for aesthetic medicine – serving both consumers and medical professionals.

“We will use our combined strengths and experience to build an aesthetic business that capitalizes on Johnson & Johnson’s broad-based commercial capabilities, worldwide surgical care footprint, and clinical scientific capabilities.”